Carrie Schinstock
0000-0002-3274-3277
13 papers found
Refreshing results…
The Banff 2022 Kidney Meeting Work Plan: Data-driven refinement of the Banff Classification for renal allografts
The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics
Apples, oranges, and anything in between: In search of the best desensitization therapy
Is the level of HLA eplet mismatch a risk factor for graft loss among kidney transplant recipients who have already formed de novo donor specific antibody?
A 2020 Banff Antibody Mediated Injury Working Group examination of international practices for diagnosing antibody mediated rejection in kidney transplantation
Estimating Alloantibody Levels in Highly‐Sensitized Renal Allograft Candidates: Using Serial Dilutions to Demonstrate a Treatment Effect in Clinical Trials
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody‐mediated rejection
The need for novel trial designs, master protocols, and research consortia in transplantation
Managing highly sensitized renal transplant candidates in the era of kidney paired donation and the new kidney allocation system: Is there still a role for desensitization?
Modeling graft loss in patients with donor‐specific antibody at baseline using the Birmingham‐Mayo (BirMay) predictor: Implications for clinical trials
Factors at de novo donor‐specific antibody initial detection associated with allograft loss: a multicenter study
Long‐term outcomes of eculizumab‐treated positive crossmatch recipients: Allograft survival, histologic findings, and natural history of the donor‐specific antibodies
De novo donor-specific antibody following BK nephropathy: The incidence and association with antibody-mediated rejection
Missing publications? Search for publications with a matching author name.